Related Experiment Videos
Caffeine or theophylline for neonatal apnoea?
J E Scanlon1, K C Chin, M E Morgan
1Regional Neonatal Intensive Care Unit, Birmingham Maternity Hospital.
Archives of Disease in Childhood
|April 1, 1992
Summary
Caffeine effectively reduces apnoeic attacks in preterm infants. A higher dose of caffeine provides a faster response, making it a recommended treatment for neonatal apnoea.
Area of Science:
- Neonatal Medicine
- Pharmacology
- Pediatric Critical Care
Background:
- Neonatal apnoea is a common condition in preterm infants.
- Caffeine and theophylline are commonly used to treat neonatal apnoea.
- Optimal dosing regimens for these medications are still being investigated.
Purpose of the Study:
- To compare the efficacy of different caffeine and theophylline dosing regimens in treating neonatal apnoea.
- To evaluate the speed of response and predictability of plasma concentrations for caffeine and theophylline.
- To determine the optimal caffeine dosage for very preterm infants.
Main Methods:
- Randomized controlled trial involving 44 infants with gestational age less than 31 weeks.
- Comparison of three treatment groups: standard-dose caffeine, high-dose caffeine, and theophylline.
- Assessment of apnoeic attack reduction within 24 hours and 8 hours.
Main Results:
- All three regimens significantly reduced apnoeic attacks within 24 hours.
- High-dose caffeine and theophylline showed significant improvement in apnoea within 8 hours.
- Caffeine offered more predictable plasma concentrations and easier daily administration.
Conclusions:
- Caffeine is recommended for neonatal apnoea treatment due to ease of administration and predictable levels.
- A higher-dose caffeine regimen than previously recommended is suggested for very preterm infants to achieve a faster response.
- Further research may explore individualized dosing strategies for neonatal respiratory support.